OPTIBODIES
DEAD

Serial Number

86004137

Owner

Nordic BioSite AB

Attorney

Michael J. Hynak

Filing Date

Jul 8, 2013

Add to watchlist:

No watchlists yet
View on USPTO

OPTIBODIES Trademark

Serial Number: 86004137 • Registration: 4528368

OPTIBODIES is a trademark filed by Nordic BioSite AB on July 8, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Nordic BioSite AB (8 trademarks)

Propellervägen 4A
Täby 18362 , SE

Entity Type: 99

Trademark Details

Filing Date

July 8, 2013

Registration Date

May 13, 2014

Published for Opposition

February 25, 2014

Cancellation Date

November 29, 2024

Goods & Services

Sanitary preparations for medical purposes; dietary supplements for humans and animals; plasters, materials for dressings; disinfectants; preparations for destroying vermin, namely, fungicides and herbicides; antibodies; human immune globulin; serums; amino acids for veterinary purposes; chemical preparation for use in medical dna analysis in the nature of nucleic acids; enzymes for medical purposes; enzymes for veterinary purposes

Chemicals used in industry, science and photography; chemicals used in agriculture, horticulture and forestry, namely, chemical preparations for the treatment of seeds; adhesives for industrial use; amino acids for industrial purposes; biochemicals, namely, polypeptides for in vitro research use; biochemicals namely, precursors for in vitro genetic engineering use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; stem cells for research or scientific purposes; reagents for scientific purposes; reagents for scientific or medical research use; reagents in kit form for conducting enzyme-linked immunosorbent assays, other than for medical or veterinary purposes; monoclonal antibodies for scientific use; chemical linking agents for scientific use in associating antibodies with radionuclides; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemical linkage compounds for scientific use in associating X-ray radiodiagnostic chemical compounds with antibodies; chemical components for producing a radio-labelled monoclonal antibody for industrial or scientific use; tagged antibodies for laboratory use; monoclonal antibodies for scientific use; reagents for scientific or medical research use; proteins for use in science; chemical preparations for use in dna analysis, other than for medical use; enzymes for scientific purposes; enzymes for technical use; enzymes, not for medical use, for detecting protein fractions; enzymes, not for medical use, for labelling protein fractions; enzymes, not for medical use, for labelling proteins; enzymes, not for medical use, for measuring protein fractions; enzymes, other than for medical use, for measuring proteins; enzymes, not for medical use, for use in detecting proteins; enzymes, not for medical or veterinary use; enzymes, not for medical use, for use in the continuous homogenous isothermal amplifications of specific dna templates; enzymes not for medical use, for use in the continuous homogenous isothermal amplifications of specific rna templates; immunological antibodies, other than for medical use; immunoglobulins, other than for medical use; Immunological antisera, other than for medical use; immunoassay reagents, other than for medical use; chemical reagents for use with immunoassay analyzers, other than for medical or veterinary use; chemicals for use in immuno-assay testing, other than medical or veterinary; tagged antibodies for laboratory use; amino acids for industrial purposes

Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; laboratory services relating to the production of monoclonal antibodies; development of pharmaceutical preparations and medicines; laboratory services; research on the subject of pharmaceuticals; pharmaceutical research services; pharmaceutical research and development; pharmaceutical research and development services

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Nov 29, 2024 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
May 13, 2023 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 30, 2020 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 30, 2020 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 29, 2020 APRE
TEAS SECTION 8 & 15 RECEIVED
May 13, 2020 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 13, 2019 REM1
REGISTERED-PRINCIPAL REGISTER
May 13, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 25, 2014 NPUB
PUBLISHED FOR OPPOSITION
Feb 25, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 5, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 23, 2014 PREV
ASSIGNED TO LIE
Jan 23, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 30, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 30, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 30, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 30, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 30, 2013 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 12, 2013 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 12, 2013 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 24, 2013 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 24, 2013 GNSL
SUSPENSION LETTER WRITTEN
Oct 24, 2013 CNSL
ASSIGNED TO EXAMINER
Oct 19, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 16, 2013 NWOS
NEW APPLICATION ENTERED
Jul 11, 2013 NWAP